Adjuvant Therapy in Prostate Cancer: Patient Identification and Treatment Options

References

References

• Smart , CR . 2000 . The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program . Cancer , 80 : 1835 – 1844 .
   Google Scholar
• Mettlin , C . 1997 . Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974–1993 . Prostate , 32 : 221 – 226 .
   Google Scholar
• Dennis , LK and Resnick , MI . 2000 . Analysis of recent trends in prostate cancer incidence and mortality . Prostate , 42 : 247 – 252 .
   Google Scholar
• Blute , ML , Bergstralh , EJ , Iocca , A , Scherer , B and Zincke , H . 2001 . Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy . J. Urol. , 165 : 119 – 125 .
   PubMed Web of Science ®Google Scholar
• Shipley WU Thames HD Sandler HM Hanks GE Zietman AL Perez CA et al. 1999 Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis JAMA 281 1598 1604
   PubMed Web of Science ®Google Scholar
• Han , M , Partin , AW , Pound , CR , Epstein , JI and Walsh , PC . 2001 . Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year John Hopkins experience . Urol. Clin. N. Am. , 28 : 555 – 565 .
   PubMed Web of Science ®Google Scholar
• Roach M 3rd Lu J Pilepich MV Asbell SO Mohiuddin M Terry R et al. 1999 Long-term survival after radiotherapy alone: radiation therapy oncology group prostate cancer trials J. Urol. 161 864 868
   Google Scholar
• Brasso , K , Friis , S , Juel , K , Jorgensen , T and Iversen , P . 1999 . Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study . J. Urol. , 161 : 524 – 528 .
   PubMed Web of Science ®Google Scholar
• Wills , ML , Sauvageot , J , Partin , AW , Gurganus , R and Epstein , JI . 1998 . Ability of sextant biopsies to predict radical prostatectomy stage . Urology , 51 : 759 – 764 .
   PubMed Web of Science ®Google Scholar
• Han M Snow PB Epstein JI Chan TY Jones KA Walsh PC et al. 2000 A neural network predicts progression for men with Gleason score versus tumors after radical prostatectomy Urology 56 994 999
   PubMed Web of Science ®Google Scholar
• Feneley , MR and Partin , AW . 2001 . Indicators of pathologic stage of prostate cancer and their use in clinical practice . Urol. Clin. N. Am. , 28 : 443 – 458 .
   PubMedGoogle Scholar
• Roach M Lu J Pilepich MV Asbell SO Mohiuddin M Terry R et al. 2000 Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group Clinical Trials Int. J. Radiat. Oncol. Biol. Phys. 47 609 615
   PubMed Web of Science ®Google Scholar
• Epstein , JI , Partin , AW , Sauvageot , J and Walsh , PC . 1996 . Prediction of progression of following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up . Am. J. Surg. Pathol. , 20 : 286 – 292 .
   PubMed Web of Science ®Google Scholar
• Blute ML Bostwick DG Seay TM Martin SK Slezak JM Bergstralh EJ et al. 1998 Pathologic classification of prostate carcinoma: the impact of margin status Cancer 82 902 908
   Google Scholar
• Iselin , CE , Robertson , JE and Paulson , DF . 1999 . Radical perineal prostatectomy: oncological outcome during a 20-year period . J. Urol. , 161 : 163 – 168 .
   PubMed Web of Science ®Google Scholar
• Epstein , JI , Pound , CR , Partin , AW and Walsh , PC . 1998 . Disease progression following radical prostatectomy in men with Gleason score 7 tumor . J. Urol. , 160 : 97 – 101 .
   Google Scholar
• D'Amico AV Whittington R Malkowicz SB Schultz D Blank K Broderick GA et al. 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969 974
   PubMed Web of Science ®Google Scholar
• Zietman , AL , Coen , JJ , Shipley , WU , Willett , CG and Efird , JT . 1994 . Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome . J. Urol. , 151 : 640 – 645 .
   PubMed Web of Science ®Google Scholar
• Partin , AW , Kattan , MW , Subong , EN , Walsh , PC , Wojno , KJ and Oesterling , JE . 1997 . Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update . JAMA , 277 : 1445 – 1451 .
   PubMed Web of Science ®Google Scholar
• D'Amico , AV , Whittington , R , Schultz , D , Malkowicz , SB , Tomaszewski , JE and Wein , A . 1997 . Outcome based staging for clinically localized adenocarcinoma of the prostate . J. Urol. , 158 : 1422 – 1426 .
   Google Scholar
• Lu-Yao , GL , Potosky , AL , Albertsen , PC , Wasson , JH , Barry , MJ and Wennberg , JE . 1996 . Follow-up prostate cancer treatments after radical prostatectomy: a population-based study . J. Natl Cancer Inst. , 88 : 166 – 173 .
   PubMedGoogle Scholar
• Bolla M Gonzalez D Warde P Dubois JB Mirimanoff RO Storme G et al. 1997 Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N. Engl. J. Med. 337 295 300
   PubMed Web of Science ®Google Scholar
• Bolla M Collette L Blank L Warde P Dubois JB Mirimanoff RO et al. 2002 Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 103 106
   PubMed Web of Science ®Google Scholar
• Hanks GE Pajak TF Porter A Grignon D Brereton H Venkatesan V Horwitz EM et al. 2003 Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92–02 J. Clin. Oncol. 21 3972 3978
   PubMed Web of Science ®Google Scholar
• Pilepich MV Caplan R Byhardt RW Lawton CA Gallagher MJ Mesic JB et al. 1997 Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85–31 J. Clin. Oncol. 15 1013 1021
   PubMed Web of Science ®Google Scholar
• Granfors , T , Modig , H , Damber , JE and Tomic , R . 1998 . Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study . J. Urol. , 159 : 2030 – 2034 .
   PubMedGoogle Scholar
• Pilepich MV Winter K John MJ Mesic JB Sause W Rubin P et al. 2001 Phase III radiation therapy oncology group (RTOG) trial 86–10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int. J. Radiat. Oncol. Biol. Phys. 50 1243 1252
   PubMed Web of Science ®Google Scholar
• Pilepich MV Winter K Lawton C Krisch RE Wolkov H Movsas B et al. 2003 Phase III trial of androgen suppression adjuvant to definitive radiotherapy. Long term results of RTOG study 85–31 Proc. Am. Soc. Clin. Oncol. 22 381 abs 1530
   Google Scholar
• Soh , S , Kattan , MW , Berkman , S , Wheeler , TM and Scardino , PT . 1997 . Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? . J. Urol. , 157 : 2212 – 2218 .
   PubMedGoogle Scholar
• Ebert T Schmitz-Drager BJ Burrig KF Miller S Pauli N Kahn T et al. 1991 Accuracy of imaging modalities in staging the local extent of prostate cancer Urol. Clin. N. Am. 18 453 457
   Google Scholar
• Stapleton AM Zbell P Kattan MW Yang G Wheeler TM Scardino PT et al. 1998 Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery Cancer 82 168 175
   PubMed Web of Science ®Google Scholar
• Thompson I Tangen C Tolcher A Crawford E Eisenberger M Moinpour C et al. 2001 Association of African-American ethnic background with survival in men with metastatic prostate cancer J. Natl Cancer Inst. 93 219 225
   PubMed Web of Science ®Google Scholar
• Carrol PR et al. 2000 Cancer of the prostate DeVita VT Jr. Hellman S Rosenberg SA Cancer: Principles and Practice of Oncology 6th Ed. Lippincott, Williams & Wilkins Philadelphia 1418 1479
   Google Scholar
• Badalament RA Miller MC Peller PA Young DC Bahn DK Kochie P O'Dowd GJ et al. 1996 An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level J. Urol. 156 1375 1380
   PubMed Web of Science ®Google Scholar
• Gao X Mohideen N Flanigan RC Waters WB Wojcik EM Leman CR et al. 2000 The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection J. Urol. 164 1982 1986
   PubMed Web of Science ®Google Scholar
• Roach M 3rd Lu J Pilepich MV Asbell SO Mohiuddin M Terry R et al. 2000 Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials Int. J. Radiat. Oncol. Biol. Phys. 47 617 627
   PubMed Web of Science ®Google Scholar
• D'Amico , AV . 2001 . Combined-modality staging for localized adenocarcinoma of the prostate . Oncology (Huntingt) , 15 : 1049 – 1059 .
   Google Scholar
• Nam RK Elhaji Y Krahn MD Hakimi J Ho M Chu W Sweet J et al. 2000 Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression J. Urol. 164 567 572
   PubMed Web of Science ®Google Scholar
• Giovannucci E Stampfer MJ Krithivas K Brown M Dahl D Brufsky A et al. 1997 The CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proc. Natl Acad. Sci. USA 94 3320 3323
   PubMed Web of Science ®Google Scholar
• Partin , AW , Hanks , GE , Klein , EA , Moul , JW , Nelson , WG and Scher , HI . 2002 . Prostate-specific antigen as a marker of disease activity in prostate cancer . Oncology (Huntingt) , 16 : 1024 – 1038 .
   PubMedGoogle Scholar
• Graves , HC , Wehner , N and Stamey , TA . 1992 . Ultrasensitive radioimmunoassay of prostate specific antigen . Clin. Chem. , 38 : 735 – 742 .
   Google Scholar
• Amling , CL , Bergstralh , EJ , Blute , ML , Slezak , JM and Zincke , H . 2001 . Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? . J. Urol. , 165 : 1146 – 1151 .
   PubMed Web of Science ®Google Scholar
• Pound , CR , Partin , AW , Eisenberger , MA , Chan , DW , Pearson , JD and Walsh , PC . 1999 . Natural history of progression after PSA elevation following radical prostatectomy . JAMA , 281 : 1591 – 1597 .
   PubMed Web of Science ®Google Scholar
• 1997 . Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel . Int. J. Radiat. Oncol. Biol. Phys. , 37 : 1035 – 1041 .
   PubMed Web of Science ®Google Scholar
• Zelefsky , MJ , Leibel , SA , Wallner , KE , Whitmore , WF Jr. and Fuks , Z . 1995 . Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostate cancer . J. Clin. Oncol. , 13 : 459 – 463 .
   Google Scholar
• Kavadi , VS , Zagars , GK and Pollack , A . 1994 . Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications . Int. J. Radiat. Oncol. Biol. Phys. , 30 : 279 – 287 .
   Google Scholar
• Critz , FA , Levinson , AK , Williams , WH , Holladay , DA and Holladay , CT . 1997 . The PSA nadir that indicates potential cure after radiotherapy for prostate cancer . Urology , 49 : 322 – 326 .
   Google Scholar
• Grossfeld GD Stier DM Flanders SC Henning JM Schonfeld W Warolin K et al. 1998 Use of second treatment following definitive local therapy for prostate cancer: data from the CaPSURE database J. Urol. 160 1398 1404
   PubMed Web of Science ®Google Scholar
• Moul , JW . 2000 . Prostate-specific antigen progression of prostate cancer . J. Urol. , 163 : 1632 – 1642 .
   PubMed Web of Science ®Google Scholar
• Cadeddu , JA , Partin , AW , DeWeese , TL and Walsh , PC . 1998 . Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy . J. Urol. , 159 : 173 – 177 .
   PubMedGoogle Scholar
• Vicini FA Ziaja EL Kestin LL Brabbins DS Stromberg JS Gonzalez JA et al. 1999 Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer Urology 54 111 117
   PubMed Web of Science ®Google Scholar
• Leventis , AK , Shariat , SF , Kattan , MW , Butler , EB , Wheeler , TM and Slawin , KM . 2001 . Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy . J. Clin. Oncol. , 19 : 1030 – 1039 .
   PubMed Web of Science ®Google Scholar
• Catton C Gospodarowicz M Warde P Panzarella T Catton P McLean M et al. 2001 Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate Radiother. Oncol. 59 51 60
   PubMed Web of Science ®Google Scholar
• Corral , DA , Pisters , LL and Von Eschenbach , AC . 1996 . Treatment options for localized recurrence of prostate cancer following radiation therapy . Urol. Clin. N. Am. , 23 : 677 – 684 .
   Google Scholar
• Thomson , IM , Rounder , JB , Spence , CR and Rodriguez , FR . 1988 . Salvage radical prostatectomy for adenocarcinoma of the prostate . Cancer , 61 : 1464 – 1466 .
   Google Scholar
• Miles BJ et al. 2000 Salvage radical prostatectomy for local recurrence of prostate cancer after radiation therapy Vogelzang NJ Miles BJ Comprehensive Textbook of Genitourinary Oncology, Lippincott, Williams & Wilkins Philadelphia 813 823
   Google Scholar
• Shekarriz , B , Upadhyay , J and Pontes , JE . 2001 . Salvage radical prostatectomy . Urol. Clin. N. Am. , 28 : 545 – 553 .
   Google Scholar
• Beyer , DC . 1999 . Permanent brachytherapy as salvage treatment for recurrent prostate cancer . Urology , 54 : 880 – 883 .
   PubMedGoogle Scholar
• Grado CL Collins JM Kriegshauser JS Balch CS Grado MM Swanson GP et al. 1999 Salvage brachytherapy for localized prostate cancer after radiotherapy failure Urology 53 2 10
   PubMedGoogle Scholar
• Miller , RJ Jr. , Cohen , JK , Shuman , B and Merlotti , LA . 1996 . Percutaneous transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma . Cancer , 77 : 1510 – 1514 .
   PubMedGoogle Scholar
• Pisters LL von Eschenbach AC Scott SM Swanson DA Dinney CP Pettaway CA et al. 1997 The efficacy and complications of salvage cryotherapy of the prostate J. Urol. 157 921 925
   PubMed Web of Science ®Google Scholar
• de la Taille A Hayek O Benson MC Bagiella E Olsson CA Fatal M et al. 2000 Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience Urology 55 79 84
   Google Scholar
• Izawa JI Madsen LT Scott SM Tran JP McGuire EJ Von Eschenbach AC et al. 2002 Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome J. Clin. Oncol. 20 2664 2671
   PubMed Web of Science ®Google Scholar
• Izawa JI Perrotte P Greene GF Scott S Levy L McGuire E et al. 2001 Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy J. Urol. 165 867 870
   Google Scholar
• Ornstein , DK , Oh , J , Herschman , JD and Andriole , GL . 1998 . Evaluation and management of the man who has failed primary curative therapy for prostate cancer . Urol. Clin. N. Am. , 25 : 591 – 601 .
   Google Scholar
• Kaplan , I , Kapp , DS and Bagshaw , MA . 1991 . Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate . Int. J. Radiat. Oncol. Biol. Phys. , 20 : 551 – 554 .
   PubMed Web of Science ®Google Scholar
• Anscher , MS , Samulski , TV , Dodge , R , Prosnitz , LR and Dewhirst , MW . 1997 . Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate . Int. J. Radial. Oncol. Biol. Phys. , 37 : 1059 – 1065 .
   Google Scholar
• Randal , J . 2002 . High-intensity focused ultrasound makes its debut . J. Natl Cancer Inst. , 94 : 962 – 964 .
   Google Scholar
• Davis , BJ , Pisansky , TM and Leibovitch , BC . 2003 . Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer . Curr. Opin. Urol. , 13 : 117 – 122 .
   PubMedGoogle Scholar
• Paulson , DF , Moul , JW and Walther , PJ . 1990 . Radical prostatectomy for clinical stage T1–2N0M0 prostatic adenocarcinoma: long-term results . J. Urol. , 144 : 1180 – 1184 .
   PubMed Web of Science ®Google Scholar
• Anscher , MS , Robertson , CN and Prosnitz , R . 1995 . Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update . Int. J. Radiat. Oncol. Biol. Phys. , 33 : 37 – 43 .
   PubMed Web of Science ®Google Scholar
• Shevlin , BE , Mittal , BB , Brand , WN and Shetty , RM . 1989 . The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor . Int. J. Radiat. Oncol. Biol. Phys. , 16 : 1425 – 1430 .
   PubMed Web of Science ®Google Scholar
• Thompson , IM , Paradelo , JC , Crawford , ED , Coltman , CA and Blumenstein , B . 1994 . An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing . Urology , 44 : 804 – 811 .
   Google Scholar
• Petrovich , Z , Lieskovsky , G , Stein , JP , Huberman , M and Skinner , DG . 2002 . Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer . BJU Int. , 89 : 604 – 611 .
   Google Scholar
• Isaacs , JT . 1984 . The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostate cancer . Prostate , 5 : 1 – 17 .
   PubMed Web of Science ®Google Scholar
• Schally , AV and Redding , TW . 1985 . Combination of long-acting microcapsules of the d-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model . Proc. Natl Acad. Sci. USA , 82 : 2498 – 2502 .
   PubMed Web of Science ®Google Scholar
• Messing , EM , Manola , J , Sarosdy , M , Wilding , G , Crawford , ED and Trump , D . 1999 . Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer . N. Engl. J. Med. , 341 : 1781 – 1788 .
   PubMed Web of Science ®Google Scholar
• Prayer-Galetti T Zattoni F Capizzi A Dal Moro F Pagano F on behalf of the Study Group 2000 Disease-free survival in patients with pathological C stage prostate cancer at radical prostatectomy submitted to adjuvant hormone treatment Eur. Urol. 38 504 abs 48
   Google Scholar
• Messing E Manola J Sarosdy M Wilding G Crawford ED 2003 Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive cancer, results at 10 years of EST 3886 J. Urol. 169 Suppl 396 abs 1480
   Google Scholar
• See WA Wirth MP McLeod DG Iversen P Klimberg I Gleason D et al. 2002 Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program J. Urol. 168 429 435
   PubMed Web of Science ®Google Scholar
• Schmidt , JD , Gibbons , RP , Murphy , GP and Bartolucci , A . 1993 . Adjuvant therapy for localized prostate cancer . Cancer , 71 : 1005 – 1013 .
   PubMed Web of Science ®Google Scholar
• Schmidt , JD , Gibbons , RP , Murphy , GP and Bartolucci , A . 1996 . Evaluation of adjuvant estramustine phosphate, cyclophosphamide, and observation only for node-positive patients following radical prostatectomy and definitive irradiation. Investigators of the National Prostate Cancer Project . Prostate , 28 : 51 – 57 .
   Google Scholar
• Wang , J , Halford , S , Rigg , A , Roylance , R , Lynch , M and Waxman , J . 2000 . Adjuvant mitozantrone chemotherapy in advanced prostate cancer . BJU Int. , 86 : 675 – 680 .
   PubMed Web of Science ®Google Scholar
• Bagley CM Jr. Lane RF Blasko JC Grimm PD Ragde H Cobb OE et al. 2002 Adjuvant chemohormonal therapy of high risk prostate carcinoma. Ten-year results Cancer 94 2728 2732
   Google Scholar